CCL2 and cancer: In the malignant microenvironment, CCL2 crosstalk with C‐C motif chemokine receptor 2 (CCR2) to modulate chemotaxis of monocytes, notably tumor‐associated monocytes, which consequently lead to the modeling of the immune microenvironment and promote cancer progression.7